296 related articles for article (PubMed ID: 12400851)
1. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
Shand BI; Lewis JG; Elder PA; Agarwal M
Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
[No Abstract] [Full Text] [Related]
2. Treatment of hypertension.
Fogo A; Kon V
Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
[TBL] [Abstract][Full Text] [Related]
3. Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study.
Okura T
Hypertens Res; 2010 Nov; 33(11):1112-3. PubMed ID: 20811385
[No Abstract] [Full Text] [Related]
4. [Treatment of hypertension in renal parenchymal diseases].
Iversen BM; Kvam FI; Svarstad E
Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
[TBL] [Abstract][Full Text] [Related]
5. [Renal effects of combined anti-hypertensive treatments].
Gallieni M; Olivi L; Mezzina N; Cozzolino M; Cusi D
Recenti Prog Med; 2010 Feb; 101(2):70-7. PubMed ID: 20433005
[TBL] [Abstract][Full Text] [Related]
6. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
7. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
9. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
11. REIN on obesity, proteinuria and CKD.
Choi ME
J Am Soc Nephrol; 2011 Jun; 22(6):990-2. PubMed ID: 21617125
[No Abstract] [Full Text] [Related]
12. Antihypertensive therapy in the presence of proteinuria.
Sarafidis PA; Khosla N; Bakris GL
Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
[TBL] [Abstract][Full Text] [Related]
13. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
14. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
15. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease.
Apperloo AJ; de Zeeuw D; de Jong PE
Kidney Int Suppl; 1994 Feb; 45():S174-8. PubMed ID: 8158890
[No Abstract] [Full Text] [Related]
16. A comparative study of losartan and enalapril on erythropoiesis and renal function in hypertensive patients with renal parenchymal disease.
Shand BI; Lynn KL
Clin Nephrol; 2000 Nov; 54(5):427-8. PubMed ID: 11105808
[No Abstract] [Full Text] [Related]
17. Antihypertensive therapy for nondiabetic nephropathy.
Maschio G
Am J Kidney Dis; 2000 Apr; 35(4):liv-lvi. PubMed ID: 10809659
[No Abstract] [Full Text] [Related]
18. Effect of diltiazem and methyldopa on gestation-related renal complications in rats with adriamycin nephrosis. Relationship to glomerular prostanoid synthesis.
Podjarny E; Haskiah A; Pomeranz A; Bernheim J; Green J; Rathaus M; Bernheim J
Nephrol Dial Transplant; 1995; 10(9):1598-602. PubMed ID: 8559476
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
Ellis D; Moritz ML; Vats A; Janosky JE
Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure, proteinuria and nephropathy in Fabry disease.
Jain G; Warnock DG
Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
